← Back to Search

Other

Higher protein, low glycemic load diet for Metabolic Syndrome (MAPS Trial)

N/A
Waitlist Available
Research Sponsored by University of Arkansas, Fayetteville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 16 weeks
Awards & highlights

Summary

This trial will test if regular potato consumption can improve cardiometabolic health in individuals with MetS.

Eligible Conditions
  • Metabolic Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Plasma glucose levels
Serum lipid levels
Secondary study objectives
Appetite
Dietary intake
Marker of appetite and sleep
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Higher Protein, Low Glycemic Load with PotatoesExperimental Treatment1 Intervention
Higher Protein, Low Glycemic Load with Potatoes (HPLG-P): low- to moderate- glycemic load meals containing white potatoes. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.
Group II: Higher Protein, Low Glycemic Load with Processed PotatoesActive Control1 Intervention
Higher Protein, Low Glycemic Load with Processed Potatoes (HPLG-PP): low- to moderate- glycemic load meals containing processed white potato products. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.
Group III: Higher Protein, Low Glycemic Load - ControlPlacebo Group1 Intervention
Higher Protein, Low Glycemic Load (HPLG-C): low- to moderate- glycemic load meals containing control carbohydrate (e.g. rice, pasta). Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing control carbohydrate sources.

Find a Location

Who is running the clinical trial?

University of Arkansas, FayettevilleLead Sponsor
21 Previous Clinical Trials
1,874 Total Patients Enrolled
~14 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top